SETTINGS

作品数：265被引量：362H指数：10
导出分析报告
相关领域：医药卫生更多>>
相关作者：陈雪莹张立军侯光海孙景陈杰更多>>
相关机构：四川大学厦门大学西南科技大学河南理工大学更多>>
相关期刊：更多>>
相关基金：国家自然科学基金国家重点基础研究发展计划World Health Organization中国博士后科学基金更多>>
-
在结果中检索

检索结果分析

结果分析中...
选择条件：
  • 期刊=Chinese Medical Journalx
共 条 记 录，以下是1-4
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Development of a prediction model to identify undiagnosed chronic obstructive pulmonary disease patients in primary care settings in China被引量：3
《Chinese Medical Journal》2023年第6期676-682,共7页Buyu Zhang Dong Sun Hongtao Niu Fen Dong Jun Lyu Yu Guo Huaidong Du Yalin Chen Junshi Chen Weihua Cao Ting Yang Canqing Yu Zhengming Chen Liming Li on behalf of the China Kadoorie Biobank Collaborative Group 
supported by the National Key Research&Development Program of China(Nos.2016YFC1303904 and 2016YFC0900500);National Natural Science Foundation of China(Nos.81941018,91846303,and 91843302)
Background:At present,a large number of chronic obstructive pulmonary disease(COPD)patients are undiagnosed in China.Thus,this study aimed to develop a simple prediction model as a screening tool to identify patients ...
关键词：Chronic obstructive pulmonary disease SCREENING Prediction model China Kadoorie Biobank 
Three-year Follow-up on the Safety and Effectiveness of Rituximab Plus Chemotherapy as First-Line Treatment of Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in Real-World Clinical Settings in China： A Prospective, Multicenter, Noninterventional Study被引量：3
《Chinese Medical Journal》2018年第15期1767-1775,共9页Jian-Qiu Wu Yong-Ping Song Li-Ping Su Ming-Zhi Zhang Wei Li Yu Hu Xiao-Hong Zhang Yu-Huan Gao Zuo-Xing Niu Ru FengTM Wei Wang Jie-Wen Peng Xiao-Lin Li Xue-Nong Ouyang Chang-Ping Wu Wei-Jing Zhang Yun Zeng Zhen Xiao Ying-Min Liang Yong-Zhi Zhuang Ji-Shi Wang Zi-Min Sun Hai Bai Tong-Jian Cui Ji-Feng Feng 
This study was supported by grants from the National Natural Science Foundation of China （No. 81570186） and the Health and Family Planning Commission of Jiangsu Province （No. H201511）.
Background： Prospective real-life data on the safety and effectiveness of rituximab in Chinese patients with diffuse large B-cell lymphoma （DLBCL） or follicular lymphoma （FL） are limited. This real-world study ai...
关键词：Asian Hematopoietic Malignancy Hepatitis B Virus Observational Study RITUXIMAB 
Interferon-Gamma Release Assay is Not Appropriate for the Diagnosis of Active Tuberculosis in High-Burden Tuberculosis Settings： A Retrospective Multicenter Investigation被引量：31
《Chinese Medical Journal》2018年第3期268-275,共8页Wan-Li Kang Gui-Rong Wang Mei-Ying Wu Kun-Yun Yang Er-Tai A Shu-Cai Wu Shu-Jun Geng Zhi-Hui Li Ming-Wu Li Liang Li Shen-Jie Tang 
Background：Interferon-gamma release assay （IGRA） has been used in latent tuberculosis （TB） infection and TB diagnosis,but the results from different high TB-endemic countries are different.The aim of this study w...
关键词：Active Tuberculosis DIAGNOSIS Interferon-Gamma Release Assay 
Validity of Chinese Version of the Composite Internationa Diagnostic Interview-3.0 in Psychiatric Settings被引量：16
《Chinese Medical Journal》2015年第18期2462-2466,共5页Jin Lu Yue-Qin Huang Zhao-Rui Liu Xiao-Lan Cao 
Background： The Composite International Diagnostic Interview-3.0 （CIDI-3.0） is a fully structured lay-administered diagnostic interview for the assessment of mental disorders according to ICD-10 and Diagnostic and ...
关键词：Composite International Diagnostic Interview CONCORDANCE Mental Disorder Reliability Structured Clinical Interviewfor Diagnostic and Statistical Manual of Mental Disorders  Fourth Edition Axis l Disorders Sensitivity： Specificity Validity 
全选清除导出
共1页<1>
检索报告 对象比较 聚类工具 使用帮助 返回顶部